Psychoneuroendocrinology
Volume 34, Issue 7 , Pages 989-995, August 2009

Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone

Department of Psychiatry, AMC University of Amsterdam, Meibergdreef 5, 1105 AZ Amsterdam, The Netherlands

Received 11 July 2008; received in revised form 23 January 2009; accepted 28 January 2009.

Summary 

Atypical antipsychotics interfere with central and peripheral neurotransmitter systems and with hormonal production. In this study we compared the effect of olanzapine and risperidone on hormonal state and sexual function (by using the Questionnaire for Sexual Dysfunction, QSD) in 40 patients with a first episode psychosis. Results were compared to those of 34 healthy controls. Patients using risperidone had significant higher prolactin levels than patients using olanzapine. Patients using olanzapine had significantly higher 17β-estradiol levels than patients using risperidone. Overall satisfaction with sexuality was less in patients compared to controls, but not different between patients using olanzapine and those using risperidone. Problems with sexual arousal were significantly higher in patients using olanzapine compared to patients using risperidone. A significantly higher frequency of problems with ejaculation and problems with insensibility of genitals were found in patients compared to healthy controls. We found no relation between medication, prolactin and 17β-estradiol levels, frequency of sexual activity, overall satisfaction with sexuality and any of the 18 sexual dysfunctions we investigated. Our results suggests that sexual dysfunction in patients with first episode psychosis might occur despite normal prolactin levels. Also, sexual dysfunction is highly prevalent in healthy controls. Awareness should be raised of potential sexual problems in young adults.

Keywords: Olanzapine, Risperidone, Schizophrenia, First episode psychosis, Sexual dysfunction, Prolactin, Estradiol

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-4530(09)00031-6

doi:10.1016/j.psyneuen.2009.01.013

Psychoneuroendocrinology
Volume 34, Issue 7 , Pages 989-995, August 2009